News Announcement

Glenmark Pharmaceuticals: Announcement under Regulation 30 (LODR)-Press Release / Media Release

Glenmark Pharmaceuticals Inc. USA launches Authorised Generic to Milnacipran Hydrochloride Tablets 12.5 mg 25 mg 50 mg and 100 mg

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.